Literature summary for 3.4.22.56 extracted from

Ganesan, R.; Jelakovic, S.; Campbell, A.J.; Li, Z.Z.; Asgian, J.L.; Powers, J.C.; Gruetter, M.G.
Exploring the S4 and S1 prime subsite specificities in caspase-3 with aza-peptide epoxide inhibitors (2006), Biochemistry, 45, 9059-9067.

Search for more literature for 3.4.22.56

Crystallization (Commentary)

Crystallization (Comment)	Organism
co-crystals of the complex between recombinant human caspase-3 and azapeptide epoxide inhibitors are grown from hanging drops	Homo sapiens

Inhibitors

Inhibitors	Comment	Organism	Structure
benzyloxycarbonyl-Asp-Glu-Val-aza-aspartyl-(S,S) Glu-Pro-CO-N(CH2Ph)2	-	Homo sapiens
benzyloxycarbonyl-Asp-Glu-Val-aza-aspartyl-(S,S) Glu-Pro-CO-NHCH2Ph	-	Homo sapiens
benzyloxycarbonyl-Asp-Glu-Val-aza-aspartyl-(S,S) Glu-Pro-COO-CH2Ph	-	Homo sapiens
benzyloxycarbonyl-Glu-Val-aza-aspartyl-(S,S) Glu-Pro-CO-NH-CH2CH2Ph	-	Homo sapiens
benzyloxycarbonyl-Leu-Glu-Val-aza-aspartyl-(S,S) Glu-Pro-CO-Ala-NH-CH2Ph	-	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Purification (Commentary)

Purification (Comment)	Organism
-	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)